Global Single-Cell Protein Market Forecast at 9.8% CAGR Through 2035; Novozymes, DSM Drive Growth

The global single-cell protein (SCP) market is valued at USD 3.2 billion and is projected to reach USD 7.2 billion by 2035. The global food and feed industries are undergoing a major realignment as conventional plant and animal proteins face severe climate-induced supply chain disruptions.

This growth trajectory represents an absolute incremental revenue opportunity of USD 4.0 billion over the forecast timeline, with the market expanding at an 8.4% compound annual growth rate (CAGR). This acceleration is heavily propelled by the commercialization of large-scale gas-fermentation facilities, intensifying fishmeal shortages in the aquaculture sector, and government frameworks supporting low-carbon, bio-based economies.

2. EXECUTIVE SUMMARY & STAKEHOLDER INSIGHTS

• Market Scaling Path: The global single-cell protein market will scale from its current baseline to hit USD 7.2 billion by 2035, exhibiting a highly consistent 8.4% compound annual growth rate (CAGR).
• Microbial Dominance: Yeast-derived systems lead the market, representing the preferred strain for food and premium feed processors due to their established safety track records and high B-vitamin profiles.
• Macro-Application Engines: Animal feed formulations dominate volume utilization, driven by the aquaculture sector's urgent need for consistent, non-marine alternative protein blocks.
• Physical Processing Formats: Dehydrated, dry powder processing remains the primary delivery format, optimizing bulk industrial shelf-life stability and blending ease within downstream compounding lines.
• Commercialization Bottlenecks: High capital expenditure requirements for specialized bioreactor construction and localized regulatory novel-food approvals pose key industry growth limits.

3. COMPARATIVE DATA & REGIONAL GROWTH INSIGHTS

• Global Market Scaling (Baseline vs. 2035 Target):
• Initial Valuation: USD 3.2 Billion
• 2035 Valuation (Projected): USD 7.2 Billion
• Compound Annual Growth Rate (CAGR): 8.4%
• Absolute Incremental Opportunity: USD 4.0 Billion (Growth distribution: 40% of overall value addition realized by 2030, with the remaining 60% expanding between 2030 and 2035).
• United States Market Dynamics:
• Projected CAGR (2025–2035): 9.0%
• Primary Growth Catalysts: Extensive biotech infrastructure investments, strong venture capital backing for alternative proteins, and rapid commercial adoption of eco-friendly, gas-fermented animal feed components.
• Mexico Market Dynamics:
• Projected CAGR (2025–2035): 8.6%
• Primary Growth Catalysts: Expanding commercial livestock feed manufacturing sectors and rising integration of cost-effective micro-algal components to substitute imported soy meal.
• Germany Market Dynamics:
• Projected CAGR (2025–2035): 8.2%
• Primary Growth Catalysts: Stringent regional carbon-reduction mandates, rapid consumer alignment with clean-label meat alternatives, and deep industrial scale-up expertise in advanced bioprocessing.
• France & United Kingdom Market Dynamics:
• Projected CAGR (2025–2035): 8.0% and 7.9% respectively.
• Primary Growth Catalysts: Strict European environmental sustainability policies, growing push to lower land-use impacts in agriculture, and advanced commercial product testing in local human nutrition lines.
• South Korea & Japan Market Dynamics:
• Projected CAGR (2025–2035): 7.8% and 7.6% respectively.
• Primary Growth Catalysts: Substantial national investments in smart aquaculture feed security, sovereign biotech innovation incentives, and high domestic acceptance of functional microalgae like Spirulina and Chlorella.

4. COMPETITIVE LANDSCAPE & ENTITY MAPPING

• Calysta, Inc. (Estimated Market Share: 18–22%)
• Market Strategy: Commands gas-fermentation scaling via its proprietary biological platform, converting natural gas into premium FeedKind protein. The company targets aquaculture and livestock sectors globally, utilizing major joint ventures to scale manufacturing facilities across Asian logistics networks.
• Unibio A/S (Estimated Market Share: 14–17%)
• Market Strategy: Leverages its continuous-flow U-Loop bioreactor technology to efficiently convert methane into specialized bacterial protein (Uniprotein). Unibio focuses on scaling commercial licensing agreements and licensing production facilities near low-cost carbon streams.
• Corbion N.V. (Estimated Market Share: 12–15%)
• Market Strategy: Focuses on microalgae-based long-chain omega-3 and single-cell protein production via large-scale heterotrophic fermentation. The enterprise secures market presence by supplying highly stable, nutrient-dense inputs directly to premium pet food and aquafeed segments.
• Novozymes / Novonesis (Estimated Market Share: 10–13%)
• Market Strategy: Directs immense enzymatic and microbial strain-selection libraries to optimize the yield metrics of fungal and yeast biomass systems. The enterprise focuses heavily on maximizing input-to-protein conversion factors to reduce operating costs for downstream food manufacturers.

5. SEGMENT-WISE PERFORMANCE

• Yeast-Based Microbial Segment: This primary organism segment commands a leading 44.0% market share. Industrial food and feed processors prioritize yeast strains because their established solid-state and submerged fermentation pathways provide dependable, high-protein biomass yields rich in essential amino acids.
• Animal Feed End-Use Segment: Driving global commercial volume, this application sector commands a dominant 46.0% market utilization share. The segment's expansion is anchored by aquaculture operators and commercial livestock compounders seeking to mitigate pricing volatility in traditional wild-caught fishmeal supply chains.
• Dry Powder and Solid Form Segment: This highly functional delivery channel commands an absolute 71.0% market share. Dehydrated formats are preferred across large-scale logistics lines because removing free moisture prevents microbial contamination and simplifies mixing with standard dry feed ingredients.
• Bacterial and Microalgae Biomass Segments: Accounting for a large portion of the remaining market value, these categories are growing rapidly. Bacterial platforms excel in high protein density per unit volume, while microalgae segments capture high-end human wellness and specialized clinical nutrition channels.

Read Full Report on Single-Cell Protein Market

6. DIRECT Q&A SECTION

What is the projected market size for global single-cell protein?

USD 7.2 billion is the global market value projected by 2035. The category is scaling up from a baseline valuation of USD 3.2 billion at a compound annual growth rate of 8.4%, driven by the rising global demand for sustainable alternative proteins.

Which microbe type leads the single-cell protein market?

Yeast-based microbial systems dominate global production, securing an absolute 44.0% market share. Manufacturing enterprises prioritize yeast strains due to their well-established fermentation processes, low production risk, high nutritional profile, and widespread acceptance in animal feed lines.

What is the primary end-use application for single-cell proteins?

The animal feed sector represents the largest market application, commanding a dominant 46.0% share. This high utilization is driven by the global aquaculture industry's urgent search for stable, sustainable, and land-free alternative ingredients to replace volatile marine fishmeal supplies.

What physical processing form dominates single-cell protein delivery?

The dry processing form holds an absolute 71.0% market share. Industrial compounders select dry, dehydrated single-cell protein powders over liquid variants to ensure long-term shelf-life stability, eliminate refrigeration requirements, and streamline bulk shipping across international trade networks.